Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)

Multi-Institutional Outcomes of Patients Aged 75 years and Older With Pancreatic Ductal Adenocarcinoma Treated With 5-Fraction Ablative Stereotactic Magnetic Resonance Image-Guided Adaptive Radiation Therapy (A-SMART)

Purpose Treatment options for pancreatic ductal adenocarcinoma (PDAC) are commonly limited for patients with advanced age due to medical comorbidities and/or poor performance status. These patients may not be candidates for more aggressive chemotherapy regimens and/or surgical resection leaving few,...

Full description

Bibliographic Details
Main Authors: JM Bryant, Russell F Palm, Roberto Herrera, Muni Rubens, Sarah E Hoffe, Dae Won Kim, Adeel Kaiser, Antonio Ucar, Jason Fleming, Fernando De Zarraga, Pamela Hodul, Santiago Aparo, Horacio Asbun, Mokenge Malafa, Ramon Jimenez, Jason Denbo, Jessica M Frakes, Michael D. Chuong
Format: Article
Language:English
Published: SAGE Publishing 2023-01-01
Series:Cancer Control
Online Access:https://doi.org/10.1177/10732748221150228

Internet

https://doi.org/10.1177/10732748221150228

Similar Items